IGF Pathway Components as Potential Biomarkers in Gastric Cancer
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262210880 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Betul Ceylaner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Türkiye. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 5. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Acibadem Mehmet Ali Aydinlar University.
Abstract (Originalsprache)
Gastric cancer is one of the leading causes of cancer-related deaths worldwide, and due to its late-stage diagnosis, the prognosis is poor. Therefore, researching biomarkers that can be used in early diagnosis and prognostic processes is crucial. Insulin-like growth factor (IGF) signaling pathways play critical roles in cellular proliferation, apoptosis, differentiation, and tumor progression. This study investigated the biomarker potential of IGF-1, IGFBP-4, IGFBP-5, and PAPP-A in gastric cancer. Forty gastric cancer patients and forty healthy individuals were included, and protein levels in serum samples were measured using the ELISA method. The findings showed that IGF-1 levels were significantly decreased in the gastric cancer group, while IGFBP-4 levels were significantly increased. IGFBP-5 levels were also lower in gastric cancer patients. In contrast, PAPP-A levels did not differ significantly between the two groups. ROC analyses revealed that IGF-1, IGFBP-4, and IGFBP-5 have good discriminatory properties in the diagnosis of gastric cancer, while PAPP-A offers low diagnostic value. In conclusion, this study suggests that IGF pathway components, particularly IGF-1, IGFBP-4, and IGFBP-5, might be promising biomarker candidates for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Türkiye.
- Department of Biochemistry and Molecular Biology, Institute of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Türkiye.
- Acibadem Labmed Clinical Laboratories, Istanbul 34752, Türkiye.
- Department of Clinical Oncology, Institute of Oncology, Istanbul University, Istanbul 34116, Türkiye.
- Department of General Surgery, Surgical Sciences, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34116, Türkiye.
ORCID-Profile: Betul Ceylaner, Furkan Sahin, Ahmet Tarik Baykal
Förderung
- Acibadem Mehmet Ali Aydinlar University
Zitieren
APA
Ceylaner, B., Sahin, F., Yildiz, A., Tastekin, D., Gok, A. F. K., & Baykal, A. T. (2025). IGF Pathway Components as Potential Biomarkers in Gastric Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210880
Vancouver
Ceylaner B, Sahin F, Yildiz A, Tastekin D, Gok AFK, Baykal AT. IGF Pathway Components as Potential Biomarkers in Gastric Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210880
BibTeX
@article{Ceylaner2025,
author = {Ceylaner, Betul and Sahin, Furkan and Yildiz, Anil and Tastekin, Didem and Gok, Ali Fuat Kaan and Baykal, Ahmet Tarik},
title = {IGF Pathway Components as Potential Biomarkers in Gastric Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262210880}
}
EUVIMED